Fortress Biotech, Inc. (FBIOP) vs Nyxoah S.A. (NYXH)

A side-by-side comparison of Fortress Biotech, Inc. and Nyxoah S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIOP vs NYXH

growth of $100 · dividends reinvested · last 5y
FBIOP +6.8% (+1.3%/yr)NYXH -94.1% (-43.3%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$107$6
FBIOP NYXH

FBIOP vs NYXH: by the numbers

  • •FBIOP is the larger company ($144M vs $142M market cap).
  • •FBIOP is profitable (163.32% net margin) while NYXH runs a net loss (-435.70%).
  • •NYXH grew revenue faster over the past five years (120.68% vs 5.39% CAGR).

Metrics side by side

Valuation

MetricFBIOPNYXH
P/E ratio6.82N/A
Forward P/E7.18N/A
P/S ratio2.105.42
P/B ratio0.881.50
FCF yield87.35%N/A

Profitability

MetricFBIOPNYXH
Gross margin62.53%63.13%
Operating margin-111.00%-827.76%
Net margin163.32%-435.70%
ROE68.12%-120.33%
ROIC-10.85%-61.13%

Growth (annualized)

MetricFBIOPNYXH
Revenue CAGR (5Y)5.39%120.68%
Total return CAGR (5Y)0.05%-45.84%

Frequently asked

Which has grown faster, FBIOP or NYXH?
Over the past five years, NYXH grew revenue faster — FBIOP at a 5.39% CAGR versus NYXH at 120.68%.
Is FBIOP or NYXH more profitable?
FBIOP runs the higher net margin — FBIOP at 163.32% versus NYXH at -435.70%.
How have FBIOP and NYXH total returns compared?
Over the past 5 years, FBIOP delivered 0.05% and NYXH delivered -45.84% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.